These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34188776)

  • 41. Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617.
    Fan LQ; Hu XY; Chen YY; Peng XL; Fu YH; Zheng YP; Yu JM; He JS
    Front Microbiol; 2021; 12():750725. PubMed ID: 34691002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phylogenicity of B.1.1.7 surface glycoprotein, novel distance function and first report of V90T missense mutation in SARS-CoV-2 surface glycoprotein.
    Stojanov D
    Meta Gene; 2021 Dec; 30():100967. PubMed ID: 34466389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corrigendum: Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex.
    Ahmed WS; Philip AM; Biswas KH
    Front Mol Biosci; 2022; 9():1018464. PubMed ID: 36339712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
    Chakraborty C; Saha A; Sharma AR; Bhattacharya M; Lee SS; Agoramoorthy G
    Mol Ther Nucleic Acids; 2021 Dec; 26():237-241. PubMed ID: 34484868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity.
    Tang H; Gao L; Wu Z; Meng F; Zhao X; Shao Y; Shi X; Qiao S; An J; Du X; Qin FX
    Front Cell Infect Microbiol; 2021; 11():813645. PubMed ID: 34912731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-protein interactions of SARS-CoV-2 and SARS: a bioinformatic analysis for plausible explanation regarding stability, divergency, and severity.
    Mitra D; Pal AK; Das Mohapatra PK
    Syst Microbiol Biomanuf; 2022; 2(4):653-664. PubMed ID: 38624777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ghosts of the past: Elemental composition, biosynthesis reactions and thermodynamic properties of Zeta P.2, Eta B.1.525, Theta P.3, Kappa B.1.617.1, Iota B.1.526, Lambda C.37 and Mu B.1.621 variants of SARS-CoV-2.
    Popovic M; Pantović Pavlović M; Pavlović M
    Microb Risk Anal; 2023 Aug; 24():100263. PubMed ID: 37234934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging variants of concern in Saudi Arabian SARS-CoV-2 isolates.
    Al-Sehemi AG; Khan MT; Muhammad S
    Saudi Med J; 2021 Dec; 42(12):1366-1368. PubMed ID: 34853144
    [No Abstract]   [Full Text] [Related]  

  • 49. Reconstruction of the most recent common ancestor sequences of SARS-Cov S gene and detection of adaptive evolution in the spike protein.
    Yuan Z; Nan Z; Pei H; Yang Z
    Chin Sci Bull; 2004; 49(12):1311-1313. PubMed ID: 32214711
    [No Abstract]   [Full Text] [Related]  

  • 50. Correction: Magazine et al. Mutations and Evolution of the SARS-CoV-2 Spike Protein.
    Magazine N; Zhang T; Wu Y; McGee MC; Veggiani G; Huang W
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution and Clinical Trend of SARS-CoV-2 Variants.
    Lorente-González M; Suarez-Ortiz M; Landete P
    Open Respir Arch; 2022; 4(2):100169. PubMed ID: 37497318
    [No Abstract]   [Full Text] [Related]  

  • 52. Evolution of SARS-CoV-2 mutational variants: Hysteria or hope for the future?
    Esmail A; Scott AJ; Dheda K
    Afr J Thorac Crit Care Med; 2021; 27(4):. PubMed ID: 35359692
    [No Abstract]   [Full Text] [Related]  

  • 53. [The evolution of SARS-CoV-2 variants and their clinical and healthcare implications].
    Eiros JM; Hernández M
    Rev Clin Esp; 2022; 222(7):414-416. PubMed ID: 35079173
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial: Computational Approaches to Foster Innovation in the Treatment and Diagnosis of Infectious Diseases.
    Lousa D; Soares CM; Barroso da Silva FL
    Front Med Technol; 2022; 4():841088. PubMed ID: 35187528
    [No Abstract]   [Full Text] [Related]  

  • 55. Daily briefing: Chances 'almost nil' of finding SARS-CoV-2 ancestor.
    Graham F
    Nature; 2022 Nov; ():. PubMed ID: 36369492
    [No Abstract]   [Full Text] [Related]  

  • 56. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.
    Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K
    J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.
    Otto SP; Day T; Arino J; Colijn C; Dushoff J; Li M; Mechai S; Van Domselaar G; Wu J; Earn DJD; Ogden NH
    Curr Biol; 2021 Jul; 31(14):R918-R929. PubMed ID: 34314723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    bioRxiv; 2021 Jul; ():. PubMed ID: 34341794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.